Tumour treating fields (TTFs) are now FDA approved for high grade glioma treatment. Novel application of this treatment modality is being assessed for paediatric brain tumours and intracranial metastatic disease. Clinical trials are being conducted to test the efficacy of this treatment modality as adjuvant therapy to current standard of care. Here we will discuss the existing literature on TTF its role in pathologies other than GBM. In addition, aspects of safety, compliance and cost are also discussed.
Journal of Pakistan Medical Association
Mirza, F. A.,
(2018). Tumour treating fields (TTFs) for paediatric brain tumours, brain metastases and other novel applications. Journal of Pakistan Medical Association, 68(11), 1729-1731.
Available at: https://ecommons.aku.edu/pakistan_fhs_mc_surg_neurosurg/165
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial 4.0 License